Does It MEK a Difference? Understanding Immune Effects of Targeted Therapy

被引:21
作者
Cooper, Zachary A. [1 ,2 ]
Reuben, Alexandre [1 ]
Austin-Breneman, Jacob [1 ]
Wargo, Jennifer A. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA
关键词
BRAF INHIBITION; T-CELLS; MELANOMA; TUMOR; COMBINATION;
D O I
10.1158/1078-0432.CCR-15-0363
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BRAF inhibitor (BRAFi) treatment enhances antitumor immunity, but is associated with increased intratumoral PD-L1 expression. MEK inhibitors (MEKi) may alter T-cell function; however, recent studies demonstrate preserved T-cell infiltrate during treatment with BRAFi/MEKi. These data have important implications for combining BRAFi/MEKi and checkpoint blockade in the treatment of melanoma. (C) 2015 AACR.
引用
收藏
页码:3102 / 3104
页数:3
相关论文
共 12 条
[1]   Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function [J].
Boni, Andrea ;
Cogdill, Alexandria P. ;
Dang, Ping ;
Udayakumar, Durga ;
Njauw, Ching-Ni Jenny ;
Sloss, Callum M. ;
Ferrone, Cristina R. ;
Flaherty, Keith T. ;
Lawrence, Donald P. ;
Fisher, David E. ;
Tsao, Hensin ;
Wargo, Jennifer A. .
CANCER RESEARCH, 2010, 70 (13) :5213-5219
[2]   Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor [J].
Callahan, Margaret K. ;
Masters, Gregg ;
Pratilas, Christine A. ;
Ariyan, Charlotte ;
Katz, Jessica ;
Kitano, Shigehisa ;
Russell, Valerie ;
Gordon, Ruth Ann ;
Vyas, Shachi ;
Yuan, Jianda ;
Gupta, Ashok ;
Wigginton, Jon M. ;
Rosen, Neal ;
Merghoub, Taha ;
Jure-Kunkel, Maria ;
Wolchok, Jedd D. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (01) :70-79
[3]   Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade [J].
Cooper, Zachary A. ;
Juneja, Vikram R. ;
Sage, Peter T. ;
Frederick, Dennie T. ;
Piris, Adriano ;
Mitra, Devarati ;
Lo, Jennifer A. ;
Hodi, Stephen ;
Freeman, Gordon J. ;
Bosenberg, Marcus W. ;
McMahon, Martin ;
Flaherty, Keith T. ;
Fisher, David E. ;
Sharpe, Arlene H. ;
Wargo, Jennifer A. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) :643-654
[4]   Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [J].
DeMatteo, Ronald P. ;
Ballman, Karla V. ;
Antonescu, Cristina R. ;
Maki, Robert G. ;
Pisters, Peter W. T. ;
Demetri, George D. ;
Blackstein, Martin E. ;
Blanke, Charles D. ;
von Mehren, Margaret ;
Brennan, Murray F. ;
Patel, Shreyaskumar ;
McCarter, Martin D. ;
Polikoff, Jonathan A. ;
Tan, Benjamin R. ;
Owzar, Kouros .
LANCET, 2009, 373 (9669) :1097-1104
[5]   Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations [J].
Flaherty, Keith T. ;
Infante, Jeffery R. ;
Daud, Adil ;
Gonzalez, Rene ;
Kefford, Richard F. ;
Sosman, Jeffrey ;
Hamid, Omid ;
Schuchter, Lynn ;
Cebon, Jonathan ;
Ibrahim, Nageatte ;
Kudchadkar, Ragini ;
Burris, Howard A., III ;
Falchook, Gerald ;
Algazi, Alain ;
Lewis, Karl ;
Long, Georgina V. ;
Puzanov, Igor ;
Lebowitz, Peter ;
Singh, Ajay ;
Little, Shonda ;
Sun, Peng ;
Allred, Alicia ;
Ouellet, Daniele ;
Kim, Kevin B. ;
Patel, Kiran ;
Weber, Jeffrey .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18) :1694-1703
[6]   BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma [J].
Frederick, Dennie T. ;
Piris, Adriano ;
Cogdill, Alexandria P. ;
Cooper, Zachary A. ;
Lezcano, Cecilia ;
Ferrone, Cristina R. ;
Mitra, Devarati ;
Boni, Andrea ;
Newton, Lindsay P. ;
Liu, Chengwen ;
Peng, Weiyi ;
Sullivan, Ryan J. ;
Lawrence, Donald P. ;
Hodi, F. Stephen ;
Overwijk, Willem W. ;
Lizee, Gregory ;
Murphy, George F. ;
Hwu, Patrick ;
Flaherty, Keith T. ;
Fisher, David E. ;
Wargo, Jennifer A. .
CLINICAL CANCER RESEARCH, 2013, 19 (05) :1225-1231
[7]   Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].
Hodi, F. Stephen ;
O'Day, Steven J. ;
McDermott, David F. ;
Weber, Robert W. ;
Sosman, Jeffrey A. ;
Haanen, John B. ;
Gonzalez, Rene ;
Robert, Caroline ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Akerley, Wallace ;
van den Eertwegh, Alfons J. M. ;
Lutzky, Jose ;
Lorigan, Paul ;
Vaubel, Julia M. ;
Linette, Gerald P. ;
Hogg, David ;
Ottensmeier, Christian H. ;
Lebbe, Celeste ;
Peschel, Christian ;
Quirt, Ian ;
Clark, Joseph I. ;
Wolchok, Jedd D. ;
Weber, Jeffrey S. ;
Tian, Jason ;
Yellin, Michael J. ;
Nichol, Geoffrey M. ;
Hoos, Axel ;
Urba, Walter J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723
[8]   PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients [J].
Kakavand, Hojabr ;
Wilmott, James S. ;
Menzies, Alexander M. ;
Vilain, Ricardo ;
Haydu, Lauren E. ;
Yearley, Jennifer H. ;
Thompson, John F. ;
Kefford, Richard F. ;
Hersey, Peter ;
Long, Georgina V. ;
Scolyer, Richard A. .
CLINICAL CANCER RESEARCH, 2015, 21 (14) :3140-3148
[9]   BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice [J].
Liu, Chengwen ;
Peng, Weiyi ;
Xu, Chunyu ;
Lou, Yanyan ;
Zhang, Minying ;
Wargo, Jennifer A. ;
Chen, Jie Qing ;
Li, Haiyan S. ;
Watowich, Stephanie S. ;
Yang, Yan ;
Frederick, Dennie Tompers ;
Cooper, Zachary A. ;
Mbofung, Rina M. ;
Whittington, Mayra ;
Flaherty, Keith T. ;
Woodman, Scott E. ;
Davies, Michael A. ;
Radvanyi, Laszlo G. ;
Overwijk, Willem W. ;
Lizee, Gregory ;
Hwu, Patrick .
CLINICAL CANCER RESEARCH, 2013, 19 (02) :393-403
[10]   The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4 [J].
Liu, Li ;
Mayes, Patrick A. ;
Eastman, Stephen ;
Shi, Hong ;
Yadavilli, Sapna ;
Zhang, Tiandian ;
Yang, Jingsong ;
Seestaller-Wehr, Laura ;
Zhang, Shu-Yun ;
Hopson, Chris ;
Tsvetkov, Lyuben ;
Jing, Junping ;
Zhang, Shu ;
Smothers, James ;
Hoos, Axel .
CLINICAL CANCER RESEARCH, 2015, 21 (07) :1639-1651